Access
This article is part of Nature's premium content.
Published online 22 December 2008 | Nature | doi:10.1038/news.2008.1323
News
Reprogrammed skin cells provide testing ground for new drugs
Induced pluripotent stem cells pass key milestone.
Skin cells from a patient with a genetic disease called spinal muscular atrophy (SMA) have been reprogrammed into stem cells that can be used as a model of the disease. The research marks an important milestone in creating and using stem cells to understand disease processes and screen drugs.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
Very glad to know that some laboratory animals are going to be relieved of pain :-)